• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以心源性休克为表现的心脏结节病经Impella和皮质类固醇脉冲疗法成功康复:一例报告

Cardiac sarcoidosis presenting with cardiogenic shock successfully recovered by Impella and corticosteroid pulse therapy: a case report.

作者信息

Hashimura Miho, Ikeda Yuki, Koitabashi Toshimi, Ako Junya

机构信息

Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-Ku, Sagamihara, Kanagawa 252-0374, Japan.

出版信息

Eur Heart J Case Rep. 2023 Feb 1;7(2):ytad045. doi: 10.1093/ehjcr/ytad045. eCollection 2023 Feb.

DOI:10.1093/ehjcr/ytad045
PMID:36793932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9924496/
Abstract

BACKGROUND

Cardiac sarcoidosis (CS) occasionally disrupts circulatory haemodynamics due to arrhythmia or cardiac dysfunction.

CASE SUMMARY

A 70-year-old woman was diagnosed with CS, then was admitted for syncope because of complete atrioventricular block and frequently non-sustained ventricular tachycardia. Although a temporary pacemaker and intravenous amiodarone were introduced, she subsequently went into cardiopulmonary arrest by ventricular fibrillation. After the return of spontaneous circulation, Impella cardiac power (CP) was introduced because of sustained hypotension and severely impaired left ventricular contraction. High-dose intravenous corticosteroid therapy was simultaneously introduced. Her atrioventricular conduction and left ventricular contraction drastically improved. Impella CP was successfully removed after 4 days of support. She was eventually administered steroid maintenance therapy and discharged.

DISCUSSION

We report a case of CS with fulminant haemodynamic collapse treated with high-dose intravenous corticosteroid therapy under Impella assistance for acute haemodynamic support. Although CS has been known as an inflammatory disease with progressive cardiac dysfunction and rapid deterioration due to fatal arrhythmias, it can be improved with steroid therapy. It was suggested that strong haemodynamic support by Impella could be a bridge to manifest the effects after introducing steroid therapy to patients with CS.

摘要

背景

心脏结节病(CS)偶尔会因心律失常或心脏功能障碍而扰乱循环血流动力学。

病例摘要

一名70岁女性被诊断为CS,随后因完全性房室传导阻滞和频繁非持续性室性心动过速而因晕厥入院。尽管植入了临时起搏器并静脉注射了胺碘酮,但她随后因心室颤动而发生心肺骤停。自主循环恢复后,由于持续低血压和左心室收缩严重受损,引入了Impella心脏动力(CP)。同时引入了大剂量静脉注射皮质类固醇治疗。她的房室传导和左心室收缩显著改善。在支持4天后成功移除了Impella CP。她最终接受了类固醇维持治疗并出院。

讨论

我们报告了一例CS伴暴发性血流动力学崩溃的病例,在Impella辅助下接受大剂量静脉注射皮质类固醇治疗以进行急性血流动力学支持。尽管CS被认为是一种炎症性疾病,会导致进行性心脏功能障碍并因致命性心律失常而迅速恶化,但类固醇治疗可以改善这种情况。有人认为,Impella提供的强大血流动力学支持可能是在对CS患者引入类固醇治疗后显现效果的桥梁。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092b/9924496/272c1c24678a/ytad045f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092b/9924496/701e9c468fea/ytad045f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092b/9924496/272c1c24678a/ytad045f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092b/9924496/701e9c468fea/ytad045f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092b/9924496/272c1c24678a/ytad045f2.jpg

相似文献

1
Cardiac sarcoidosis presenting with cardiogenic shock successfully recovered by Impella and corticosteroid pulse therapy: a case report.以心源性休克为表现的心脏结节病经Impella和皮质类固醇脉冲疗法成功康复:一例报告
Eur Heart J Case Rep. 2023 Feb 1;7(2):ytad045. doi: 10.1093/ehjcr/ytad045. eCollection 2023 Feb.
2
A successful bridge to recovery with Impella 5.0 and subsequent hybrid cardiac resynchronization therapy in systemic right ventricle failure: a case report.应用Impella 5.0成功过渡到康复并随后进行系统性右心室衰竭的混合心脏再同步治疗:一例报告
Eur Heart J Case Rep. 2023 Apr 30;7(5):ytad214. doi: 10.1093/ehjcr/ytad214. eCollection 2023 May.
3
Impella-Induced Incessant Ventricular Tachycardia.Impella 引起的持续性室性心动过速。
Ochsner J. 2019 Fall;19(3):248-251. doi: 10.31486/toj.18.0018.
4
Successful treatment of acute left main coronary artery disease with a drug-coated balloon under left ventricular unloading using Impella: a case report.使用Impella在左心室卸载情况下通过药物涂层球囊成功治疗急性左主干冠状动脉疾病:一例报告
Eur Heart J Case Rep. 2024 Aug 22;8(9):ytae443. doi: 10.1093/ehjcr/ytae443. eCollection 2024 Sep.
5
Severe ischaemic cardiogenic shock with cardiac arrest and prolonged asystole: a case report.伴有心脏骤停和长时间心搏停止的严重缺血性心源性休克:一例病例报告
Eur Heart J Case Rep. 2018 Jul 27;2(3):yty088. doi: 10.1093/ehjcr/yty088. eCollection 2018 Sep.
6
Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricle.在大型动物模型中,使用Impella CP对因左心室衰竭导致的严重心源性休克进行卸载:对右心室的影响。
Intensive Care Med Exp. 2020 Aug 12;8(1):41. doi: 10.1186/s40635-020-00326-y.
7
Left Impella®-device as bridge from cardiogenic shock with acute, severe mitral regurgitation to MitraClip®-procedure: a new option for critically ill patients.左心Impella®装置作为从心源性休克合并急性重度二尖瓣反流过渡到MitraClip®手术的桥梁:危重症患者的新选择。
Eur Heart J Acute Cardiovasc Care. 2021 May 25;10(4):415-421. doi: 10.1093/ehjacc/zuaa031.
8
High-risk catheter ablation of refractory atrial fibrillation using Impella CP in a patient with cardiogenic shock.使用 Impella CP 在心源性休克患者中进行高危导管消融治疗难治性心房颤动。
Pacing Clin Electrophysiol. 2020 Oct;43(10):1205-1209. doi: 10.1111/pace.14037. Epub 2020 Sep 4.
9
Unloading, ablation, bridging and transplant: different indications and treatments using the Impella 5.5 as longer-term circulatory support in one patient-an interdisciplinary case report.卸载、消融、搭桥和移植:在一名患者中使用Impella 5.5作为长期循环支持的不同适应症和治疗方法——一份跨学科病例报告
Eur Heart J Case Rep. 2023 Jul 3;7(7):ytad293. doi: 10.1093/ehjcr/ytad293. eCollection 2023 Jul.
10
Outcomes of Impella CP insertion during cardiac arrest: A single center experience.心搏骤停期间植入 Impella CP 的结果:单中心经验。
Resuscitation. 2020 Feb 1;147:53-56. doi: 10.1016/j.resuscitation.2019.12.014. Epub 2019 Dec 28.

引用本文的文献

1
Fulminant Cardiac Sarcoidosis Successfully Treated With Aggressive Immunosuppressive Therapy.积极免疫抑制治疗成功治愈暴发性心脏结节病
Case Rep Cardiol. 2025 Mar 11;2025:1350557. doi: 10.1155/cric/1350557. eCollection 2025.

本文引用的文献

1
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.2022年欧洲心脏病学会室性心律失常患者管理和心脏性猝死预防指南
Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
2
A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock.一种标准化且全面的心源性休克管理方法。
JACC Heart Fail. 2020 Nov;8(11):879-891. doi: 10.1016/j.jchf.2020.09.005.
3
JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis - Digest Version.
《日本循环学会2016年心脏结节病诊断与治疗指南 - 摘要版》
Circ J. 2019 Oct 25;83(11):2329-2388. doi: 10.1253/circj.CJ-19-0508. Epub 2019 Oct 9.
4
A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis.心脏淀粉样变中心脏移植和桥接移植机械循环支持治疗结果的当代分析。
J Card Fail. 2018 Jun;24(6):384-391. doi: 10.1016/j.cardfail.2018.02.009. Epub 2018 Mar 1.
5
Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology.Takotsubo 综合征的现有知识状况:欧洲心脏病学会心力衰竭协会 Takotsubo 综合征工作组的立场声明。
Eur J Heart Fail. 2016 Jan;18(1):8-27. doi: 10.1002/ejhf.424. Epub 2015 Nov 9.
6
Cardiac sarcoidosis: clinical manifestations, imaging characteristics, and therapeutic approach.心脏结节病:临床表现、影像学特征及治疗方法
Clin Med Insights Cardiol. 2014 Nov 19;8(Suppl 1):31-7. doi: 10.4137/CMC.S15713. eCollection 2014.
7
HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.心脏结节病相关心律失常诊断与管理的HRS专家共识声明
Heart Rhythm. 2014 Jul;11(7):1305-23. doi: 10.1016/j.hrthm.2014.03.043. Epub 2014 May 9.
8
Cardiac sarcoidosis mimicking Takotsubo syndrome.酷似Takotsubo综合征的心脏结节病
Bosn J Basic Med Sci. 2008 Aug;8(3):234-8. doi: 10.17305/bjbms.2008.2924.
9
National survey on status of steroid therapy for cardiac sarcoidosis in Japan.日本心脏结节病类固醇治疗现状的全国性调查。
Sarcoidosis Vasc Diffuse Lung Dis. 2005 Oct;22(3):210-3.
10
Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis.长期皮质类固醇治疗对心脏结节病患者左心室重构的预防作用
Am J Cardiol. 2005 Jan 1;95(1):143-6. doi: 10.1016/j.amjcard.2004.08.083.